Cited by 180Systemic Lupus Erythematosus ResearchReproductive System and PregnancyBlood Coagulation and Thrombosis Mechanisms

First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss

Bramham, Kate, Thomas, Mari, Nelson-Piercy, Catherine, Khamashta, Munther, Hunt, Beverley J.·2011·Blood

Abstract

The objective of this study was to assess pregnancy outcome in women with a history of refractory antiphospholipid antibody-associated pregnancy loss(es) who were treated with early low-dose prednisolone in addition to aspirin and heparin. Eighteen women with antiphospholipid antibodies who had refractory pregnancy loss(es) were given prednisolone (10 mg) from the time of their positive pregnancy test to 14 weeks' gestation. Before low-dose prednisolone was given as treatment, 4 (4%) of 97 pregnancies had resulted in live births. Among 23 pregnancies supplemented with prednisolone, 9 women had 14 live births (61%), including 8 uncomplicated pregnancies. The remainder were complicated by preterm delivery, preeclampsia, and/or small-for-gestational-age infants. There were 8 first-trimester miscarriages and 1 ectopic pregnancy. There were no fetal deaths after 10 weeks' gestation and no evidence of maternal morbidity. The addition of first-trimester low-dose prednisolone to conventional treatment is worthy of further assessment in the management of refractory antiphospholipid antibody-related pregnancy loss(es), although complications remain elevated.

Integrity signals

Registry

Crossref · 10.1182/blood-2011-02-339234

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Evidence directly supporting the addition of HCQ or low-dose prednisolone in the first trimester is based on two small observational studies with limited representativeness.

    “Evidence directly supporting these treatment options is based on two small observational studies with limited representativeness.56 57”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bramham, K., Thomas, M., Nelson-Piercy, C., Khamashta, M., & Hunt, B. J.
Affiliations
  • King's College London (GB)
  • National Health Service (GB)
  • Obstetric Medicine, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom;
  • Guy's and St Thomas' NHS Foundation Trust (GB)
Corresponding author
  • Bramham, Kate
  • Thomas, Mari
Venue
Blood
Published
2011-06-23
Volume
117
Issue
25
Pages
6948-6951
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2049326681
Cited by
180
References
27
Citations by year
2026: 4 · 2025: 4 · 2024: 13 · 2023: 7 · 2022: 13 · 2021: 10 · 2020: 17 · 2019: 19 · 2018: 12 · 2017: 13 · 2016: 17 · 2015: 15 · 2014: 15 · 2013: 10 · 2012: 6
FWCI
8.42
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
  • National Institute for Health and Care Research (DRF-2009-02-18)
  • British Heart Foundation (FS/10/013/28073)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords
antiphospholipid antibodies, miscarriage, low-dose prednisolone, aspirin, heparin, pregnancy outcomes, ectopic pregnancy, preterm birth, preeclampsia, small for gestational age
MeSH terms
Abortion, Spontaneous, Adult, Anti-Inflammatory Agents, Anticoagulants, Aspirin, Female, Heparin, Humans, Prednisolone, Pregnancy, Pregnancy Trimester, First, Antiphospholipid Syndrome, Antibodies, Antiphospholipid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review